Skip to Content

Lemborexant Approval Status

FDA Approved: No
Generic name: lemborexant
Company: Eisai Inc.
Treatment for: Insomnia

Lemborexant is dual orexin receptor antagonist (DORA) in development for the treatment of insomnia.

Development Status and FDA Approval Process for lemborexant

DateArticle
Mar 12, 2019Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Jan 15, 2019New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States
Oct 28, 2016Eisai to Initiate Phase II Clinical Study of Dual Orexin Receptor Antagonist Lemborexant in Patients with Irregular Sleep-Wake Rhythm Disorder and Dementia

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide